Results for tag: "Urea Cycle Disorder Drug"

The Urea Cycle Disorder Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. Urea Cycle Disorder Drugs are used to treat a variety of metabolic disorders, including urea cycle disorders, which are caused by a deficiency of certain enzymes in the liver. These drugs are used to reduce the levels of ammonia in the blood, which can be toxic to the body. They can also help to reduce the risk of complications associated with urea cycle disorders, such as liver failure. The Urea Cycle Disorder Drug market is highly competitive, with a number of companies offering products to treat these disorders. Companies such as Amicus Therapeutics, BioMarin Pharmaceuticals, and Ultragenyx Pharmaceuticals are all involved in the development and marketing of Urea Cycle Disorder Drugs. Other companies such as Sanofi, Pfizer, and Novartis are also involved in the market, offering products to treat these disorders. Show Less Read more